Reference:
Merce Pinada
Abstract:
Proposed in this project, a multicenter trial (cooperation between different hospitals in Israel and the U.S., including the John Hopkins Hospital and three other medical centers), with proposals for dealing with disruptive behavior, including irritability, screaming, biting, self-mutilation, anxiety, inattention and hyperactivity. The main objective of this paper is to improve the mood and behavior with the use of venlafaxine, a reuptake inhibitor of serotonin and norepinephrine (SNRI), and compare the results with citalopram, a selective reuptake inhibitor serotonin (SSRI) to determine the drug more effectively and with less associated morbidity.
PROJECT DETAILS
beginning: 2009.
end: 2009.
Country of research: Spain
Counry of funding source: Spain
Funding organization: Fondo Biorett
Financing: PRIVATE FUNDERS – 35 207 €